Link to Zipped WordPerfect Minutes 10K bytes





MINUTES OF THE SENATE HEALTH AND HUMAN SERVICES
    STANDING COMMITTEE
Room 250, State Capitol

February 20, 2013

Members Present:         Sen. Evan J. Vickers, Chair
                Sen. Allen M. Christensen
                Sen. Brian E. Shiozawa
                Sen. Daniel W. Thatcher
                Sen. Luz Robles         

Staff Present:            Mr. Mark D. Andrews, Policy Analyst
                Ms. Nancy A. Skidmore, Committee Secretary
    
A list of visitors and a copy of handouts are filed with the committee minutes.

Chair Vickers called the meeting to order at 4:02 p.m.
    
Approval of Minutes

MOTION:    Sen. Christensen moved to approve the minutes of Feb. 12 and Feb. 14, 2013. The         motion passed unanimously with Sens. Robles and Thatcher absent for the vote.

S.B. 194     Pharmacy Practice Act Amendments (E. Vickers)     

 Sen. Vickers presented and explained the bill.

Spoke in favor of the bill:    Ms. Missy Duke, Pharmacist, Utah Society of Health-System                     Pharmacists
                
Spoke to the bill:        Ms. Michelle McOmber, Utah Medical Association
                    
MOTION:     Sen. Christensen moved to amend S.B. 194 as follows:


1.    Page 10, Line 302 through Page 11, Line 313 :    

             302          (b) "Practice as a licensed pharmacy technician" does not include:
             303          (i) performing a drug utilization review, prescription drug order clarification from a
             304      prescriber, []
{   [   } final review of the prescription      {   ]   } [and prescribed drug prepared for dispensing,]        ,      

             305      dispensing of the drug, or counseling a patient with respect to a prescription drug;
             306          (ii) except as permitted by rules made by the division in consultation with the board
{   :

             307          (A) final review of a prescription; or
             308          (B)   }
  ,       final review of a prescribed drug prepared for dispensing;

             309          [(ii)] (iii) counseling regarding nonprescription drugs and dietary supplements unless

             310      delegated by the supervising pharmacist; or
             311          [(iii)] (iv) receiving new prescription drug orders when communicating telephonically
             312      or electronically unless the original information is recorded so the pharmacist may review the
             313      prescription drug order as transmitted.


The motion passed unanimously with Sens. Robles and Thatcher absent for the vote.

MOTION:     Sen. Thatcher moved to amend S.B. 194, as follows:


1.    Page 1, Line 16 :    

             16          .    amends pharmacy technician licensure qualifications;
 

    . authorizes, under certain circumstances, the dispensing of one or more refills at the time a legend drug prescription is dispensed;  


2.    Page 2, Line 28 :    

             28          58-17b-612, as last amended by Laws of Utah 2010, Chapter 101
 

ENACTS:
    58-17b-608.1, Utah Code Annotated 1953  


3.    Page 14, Line 428 :    

             428      with the division.
      Section 4. Section 58-17b-608.1 is enacted to read:

     58-17b-608.1. Refills of legend drug prescriptions.
    If a prescription for a legend drug includes authorization for one or more refills, a pharmacist or pharmacy intern may dispense one or more of the refills at the time the drug is dispensed, if:
    (1)    the drug is not a controlled substance;
    (2)    the prescription does not include "Dispense as Written," "DAW", or some other notation having similar meaning;
    (3)    the total dosage units dispensed, including the units for both the prescription and any refills, do not exceed a 180-day supply; and
    (4)    in the professional judgment of the pharmacist or pharmacy intern the refill, or refills, should be dispensed at the time the prescription is dispensed.  


Renumber remaining sections accordingly.

The motion passed unanimously with Sens. Robles and Thatcher absent for the vote.

MOTION:     Sen. Christensen moved to pass S.B.194, as amended, out favorably. The
        motion passed unanimously with Sen. Robles and Thatcher absent for the vote.

S.B. 206    Office of Medicaid Inspector General Amendments (A. Christensen)

Sen. Christensen presented and explained the bill.

Spoke in favor of the bill:    Mr. Lee Wyckoff, Medicaid Inspector General

Spoke to the bill:        Mr. Dave Guest, Utah Hospital Association

MOTION:    Sen. Shiozawa moved to proceed to the next item on the agenda. The motion         failed with Sens. Vickers, Christensen, and Thatcher voting in opposition.         
MOTION:    Sen. Christensen moved to pass S.B. 206 out favorably. The motion passed         unanimously with Sen. Robles absent for the vote.

Sen. Shiozawa declared a conflict of interest.

S.B. 78    Pharmacy Act Amendments (J. S. Adams)

Sen. Adams presented and explained the bill.

Spoke in favor of the bill:    Dr. Thomas Felix, Director, Global Regulatory Affairs, Amgen
                Mr. Wynn Phillips, Retire Safe
                Ms. Michelle McOmber, Utah Medical Association

Spoke to the bill:        Mr. Dave Davis, President, Retail Food Association    
                Mr. Lincoln Shurtz, Utah League of Cities and Towns
                Ms. Barbara Boner, Associate Director, State & External Affairs,                     Novartis Pharmaceuticals
                Greg Curtis, Contact Government Affairs Representative, Amgen
                Paul Rogers, Generic Pharmaceutical Association
                Frank Agnawelli, Express Scripts

MOTION:    Sen. Thatcher moved to amend S.B. 78 as follows:


1.    Page 17, Lines 501 through 509 :    

             501          (7) A pharmacist or pharmacy intern who substitutes an interchangeable biosimilar
             502      product for a prescribed biological product shall
  communicate the substitution to the purchaser. The interchangeable biosimilar product container shall be labeled with the name of the interchangeable biosimilar product dispensed, and the pharmacist, pharmacy intern, or pharmacy technician shall indicate on the file copy of the prescription both the name of the prescribed biological product and the name of the interchangeable biosimilar product dispensed in its place.            {   :

             503          (a) communicate the substitution to the purchaser;
             504          (b) ensure that the interchangeable product container is labeled with the name and the
             505      manufacturer of the interchangeable biosimilar product dispensed; and
             506          (c) indicate on the file copy of the prescription:

             507          (i) the name and the manufacturer of the prescribed biological product; and
             508          (ii) the name and the manufacturer of the interchangeable biosimilar product dispensed
             509      in place of the prescribed biological product.   }

2.    Page 17, Lines 510 through 516 :    

             510          (8) A pharmacist or pharmacy intern who substitutes an interchangeable biosimilar
             511      product for a prescribed biological product shall:
             512          (a) notify the prescriber in writing
  , by fax, telephone, or electronic transmission       of the substitution, as soon as practicable, but not

             513      later than three business days after dispensing the interchangeable biosimilar product in place
             514      of the prescribed biological product; and
             515          (b) include the name and manufacturer of the interchangeable biosimilar product
             516      substituted.

3.    Page 17, Lines 517 through 521 :    

             517          
{   (9) The pharmacist or pharmacy intern shall:

             518          (a) retain a written record of the substitution for at least five years; and
             519          (b) include the name and manufacturer of the interchangeable product substituted.   }
             520          
{   (10)   }        (9)       A licensed medical practitioner who fails to specify that no substitution is

             521      authorized does not constitute evidence of negligence.



The motion passed unanimously with Sen. Robles absent for the vote.

MOTION:     Sen. Robles moved to pass S.B. 78, as amended, out favorably. The motion
        passed with Sen.Vickers voting in opposition and Sen. Christensen absent for the         vote.        

MOTION:    Sen. Robles moved to adjourn the meeting. The motion passed unanimously with
        Sen. Christensen absent for the vote.


Chair Vickers adjourned the meeting at 5:25 p.m.    

Minutes reported by Nancy A. Skidmore, Secretary.




Sen. Evan J. Vickers, Committee Chair